128 related articles for article (PubMed ID: 6741861)
1. Phase II trial of PCNU in advanced colorectal carcinoma. An Eastern Cooperative Oncology Group pilot study.
Earhart RH; Moertel C; Hahn RG; Woodhouse CL; Ramirez G; Engstrom PF
Am J Clin Oncol; 1984 Aug; 7(4):309-12. PubMed ID: 6741861
[TBL] [Abstract][Full Text] [Related]
2. Phase II trial of PCNU in advanced malignant melanoma: an Eastern Cooperative Oncology Group pilot study.
Earhart RH; Muggia FM; Golomb FM
Invest New Drugs; 1985; 3(3):297-301. PubMed ID: 4066223
[TBL] [Abstract][Full Text] [Related]
3. PCNU: phase II evaluation in advanced colorectal carcinoma.
Pazdur R; Samson MK; Baker LH
Invest New Drugs; 1988 Jun; 6(2):93-5. PubMed ID: 3170134
[TBL] [Abstract][Full Text] [Related]
4. Therapy of advanced gastrointestinal cancer with the nitrosoureas.
Moertel CG
Cancer Chemother Rep 3; 1973 May; 4(3):27-34. PubMed ID: 4748872
[No Abstract] [Full Text] [Related]
5. Phase II evaluation of 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosourea (PCNU, NSC 95466) in patients with metastatic colorectal cancer.
Bedikian AY; Stroehlein JR; Karlin DA; Bennetts RW; Stewart DJ; Bodey GP
Am J Clin Oncol; 1983 Feb; 6(1):49-52. PubMed ID: 6837507
[TBL] [Abstract][Full Text] [Related]
6. [Phase II study of the water-soluble nitrosourea compound ACNU in advanced colorectal carcinomas].
Fiebig HH; Wellens W; Peukert M; Henss H; Arnold H; Westerhausen M; Löhr GW
Onkologie; 1984 Dec; 7(6):370-7. PubMed ID: 6396565
[TBL] [Abstract][Full Text] [Related]
7. A phase II study of chlorozotocin in advanced large bowel carcinoma. A cooperative study between two institutions.
Schutt AJ; Hoth D; Moertel CG; Schein PS; Rubin J; O'Connell MJ
Am J Clin Oncol; 1984 Oct; 7(5):507-11. PubMed ID: 6239538
[TBL] [Abstract][Full Text] [Related]
8. Phase II trial of PCNU in breast carcinoma.
Rubins JM; Taylor SG
Invest New Drugs; 1989 Jul; 7(2-3):239-41. PubMed ID: 2793380
[TBL] [Abstract][Full Text] [Related]
9. Phase II study of PCNU in colorectal carcinoma.
Mitchell EP; Killen JY; Smith FP; Willis LL; Schein PS; Woolley PV
Cancer Treat Rep; 1981; 65(11-12):1129-30. PubMed ID: 7296558
[No Abstract] [Full Text] [Related]
10. Phase II study of doxifluridine in advanced colorectal adenocarcinoma.
Abele R; Alberto P; Kaplan S; Siegenthaler P; Hofmann V; Ryssel HJ; Hartmann D; Holdener EE; Cavalli F
J Clin Oncol; 1983 Dec; 1(12):750-4. PubMed ID: 6230419
[TBL] [Abstract][Full Text] [Related]
11. Phase II trail of PCNU in refractory advanced breast cancer.
Kavanagh JJ; Yap HY; Blumenschein GR; Stewart D; Bodey GP
Am J Clin Oncol; 1982 Jun; 5(3):249-51. PubMed ID: 7081144
[TBL] [Abstract][Full Text] [Related]
12. A phase II trial of 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosourea (PCNU, NSC 95466) in recurrent malignant brain tumors.
Feun LG; Stewart DJ; Leavens ME; Burgess MA; Savaraj N; Benjamin RS; Bodey GP
J Neurooncol; 1983; 1(1):45-8. PubMed ID: 6678305
[TBL] [Abstract][Full Text] [Related]
13. Phase I study of intracarotid PCNU.
Stewart DJ; Grahovac Z; Russel NA; Hugenholtz H; Gupta S; Benoit BC; Richard MT; Maroun JA; Hopkins HS; Locke L
J Neurooncol; 1987; 5(3):245-50. PubMed ID: 3681387
[TBL] [Abstract][Full Text] [Related]
14. PCNU and recurrent childhood brain tumors.
Allen JC; Hancock C; Walker R; Tan C
J Neurooncol; 1987; 5(3):241-4. PubMed ID: 3681386
[TBL] [Abstract][Full Text] [Related]
15. CBDCA: phase II evaluation in advanced colorectal carcinoma.
Pazdur R; Samson MK; Baker LH
Am J Clin Oncol; 1987 Apr; 10(2):136-8. PubMed ID: 3551576
[TBL] [Abstract][Full Text] [Related]
16. PCNU in advanced adenocarcinoma of the ovary: a phase II study.
Decker DA; Samson MJ; Baker LH
Cancer Treat Rep; 1983 May; 67(5):511-2. PubMed ID: 6850668
[No Abstract] [Full Text] [Related]
17. The lethal activity and repair inhibition capacity of 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosourea (NSC 95466, PCNU), a nitrosourea with low carbamoylating activity.
Drewinko B; Yang LY
Invest New Drugs; 1983; 1(3):197-202. PubMed ID: 6678867
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapy of advanced measurable colon and rectal carcinoma with oral 5-fluorouracil, alone or in combination with cyclophosphamide or 6-thioguanine, with intravenous 5-fluorouracil or beta-2'-deoxythioguanosine or with oral 3(4-methyl-cyclohexyl)-1(2-chlorethyl)-1-nitrosourea: a Phase II-III study of the Eastern Cooperative Oncology Group (EST 4273).
Douglass HO; Lavin PT; Woll J; Conroy JF; Carbone P
Cancer; 1978 Dec; 42(6):2538-45. PubMed ID: 365312
[TBL] [Abstract][Full Text] [Related]
19. Phase II evaluation of 1-(2-chloroethyl)-3-(2,6-dioxo-(piperidyl)-1 nitrosourea (PCNU)(NSC-95466) in patients with advanced carcinoma of the lung.
Ratanatharathorn V; Samson MK; Haas CD; Cummings GD; O'Connor EJ; Baker LH
Am J Clin Oncol; 1983 Feb; 6(1):99-102. PubMed ID: 6837509
[TBL] [Abstract][Full Text] [Related]
20. Therapy of advanced colorectal cancer with a combination of 5-fluorouracil, methyl-1,3-cis(2-chlorethyl)-1-nitrosourea, and vincristine.
Moertel CG; Schutt AJ; Hahn RG; Reitemeier RJ
J Natl Cancer Inst; 1975 Jan; 54(1):69-71. PubMed ID: 1117460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
